OTC Antitussive Menthol Chewing Gum Requires NDA Deviation – FDA
This article was originally published in The Tan Sheet
Executive Summary
A menthol-containing topical antitussive drug with chewing gum as a delivery form necessitates submission of an NDA deviation, FDA states